How Can You Effectively Prepare NIH Research Project Grant Applications for Due Dates in 2025 and Beyond? 

March 25, 2025

NIH has been hard at work over the last two years developing guidance and training to help prepare the community for the implementation of the simplified review framework that went into effect on January 25, 2025 and applies to applications for most research project grants. The framework is a new way of reviewing the same research strategies you’ve always developed, which means neither the components nor the structure of your application are expected to change. 

Find NIH Funding Information More Quickly and Easily with RCDC’s New Look and Feel

March 20, 2025

NIH recently launched several enhancements to allow the public to more easily and quickly find funding information for various NIH research areas. The new look and feel of the NIH Research, Condition, and Disease Categorization (RCDC) Categorical Spending webpage adds to NIH’s long-standing efforts to enhance transparency and accountability into NIH funding decisions and the research areas NIH supports.

To Do in 2025: Keep Your eRA Personal Profile Updated

January 15, 2025

The Personal Profile module in eRA Commons is where you — as a principal investigator, award recipient, trainee, reviewer or other Commons user — tell NIH and other awarding agencies about yourself. Awarding agencies need to know about you to grant awards, process those awards and more. Here are a few reasons that it is extremely important to keep your Personal Profile updated.  

NIH Implementation of the U.S. Government Policy for Oversight of Dual Use Research of Concern (DURC) and Pathogens with Enhanced Pandemic Potential (PEPP)

January 14, 2025

NIH has issued agency-specific information regarding its implementation of the U.S. Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (DURC/PEPP Policy). The policy, which goes into effect May 6, 2025, is a unified federal oversight framework for conducting and managing certain types of federally funded life sciences research on biological agents and toxins.